Cambridge-based CN Bio Innovations is one of the leading bioengineering companies specialising in innovative lab technologies. Its technologies can replicate the micro-environments, biological processes, and cell-cell interactions that occur in vivo and bridge the gap between traditional cell culture assays as well as human studies.
CN Bio Innovations improves drug discovery and reduces research and development costs. This bioengineering company aims to provide systems that generate clinically translatable data that can enhance the development of tomorrow’s medicines.